0
Skip to Content
Rambam AG
Get in Touch
Rambam AG
Get in Touch
Get in Touch
press Maria Parshenkova 2022-05-23 press Maria Parshenkova 2022-05-23

123 Accelerator Announces New Investments in Oncology, Autoimmune Disease & Neuroinflammation Therapeutics

123 Accelerator, an accelerator program backed by the San Diego-based venture company Torrey Pines Investment, has announced investments in Ogwen Therapeutics, Llydaw Therapeutics and Mwyngil Therapeutics.

Read More
success story Maria Parshenkova 2022-02-28 success story Maria Parshenkova 2022-02-28

123 Accelerator Announces Investments in Virology Start-Up Trawsfynydd’s Novel Virology Programs

123 Accelerator, an accelerator program backed by the San Diego-based venture company Torrey Pines Investment, has announced investments in a virology start-up Trawsfynydd Therapeutics, together with OrbiMed Advisors.

Read More
success story Maria Parshenkova 2021-09-14 success story Maria Parshenkova 2021-09-14

123 Accelerator Announces the Launch of Gwynant Therapeutics and Celyn Therapeutics to Develop Novel Small Molecules for Oncology Targets

123 Accelerator, an accelerator program backed by the San Diego-based venture company Torrey Pines Investment, has announced two new start-up investments together with OrbiMed Advisors.

Read More
tips Maria Parshenkova 2021-04-29 tips Maria Parshenkova 2021-04-29

123 Accelerator Announces New Investments in Cancer-, Inflammation- and Neurology-Focused Therapeutics

123 Accelerator, an accelerator program backed by the San Diego-based venture company Torrey Pines Investment, has announced multiple start-up and follow-on investment rounds together with OrbiMed and a start-up investment in a European science-based venture, together with OrbiMed and BioGeneration Ventures (BGV).

Read More
Maria Parshenkova 2020-07-30 Maria Parshenkova 2020-07-30

123 Accelerator of Torrey Pines Investment in Breakthrough Cancer Programs Together with OrbiMed

123 Accelerator, an accelerator program backed by the San Diego-based venture company Torrey Pines Investment, announces an up to $28.5M seed investment together with OrbiMed in four companies: Loch Lomond Therapeutics, Loch Eil Therapeutics, Loch Ness Therapeutics and Llyn Bala Therapeutics.

Read More
Maria Parshenkova 2019-10-29 Maria Parshenkova 2019-10-29

123 Accelerator Invests in Developing Novel Highly-Specific Approaches to Treatment of Neurodegenerative Diseases Based on Previously Unrecognized Protein-Protein Interactions

123 Accelerator, announced today its plans to invest in a cutting-edge research program based out of the University of Turku (UTU), Finland.

Read More